BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9402904)

  • 1. Cost-effectiveness of inpatient substance abuse treatment.
    Barnett PG; Swindle RW
    Health Serv Res; 1997 Dec; 32(5):615-29. PubMed ID: 9402904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving cost-effectiveness in a substance abuse treatment program.
    Francis E; Hughes P; Schinka J
    Psychiatr Serv; 1999 May; 50(5):633-5. PubMed ID: 10332897
    [No Abstract]   [Full Text] [Related]  

  • 4. Does case mix matter for substance abuse treatment? A comparison of observed and case mix-adjusted readmission rates for inpatient substance abuse treatment in the Department of Veterans Affairs.
    Phibbs CS; Swindle RW; Recine B
    Health Serv Res; 1997 Feb; 31(6):755-71. PubMed ID: 9018215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs.
    Peterson KA; Swindle RW; Phibbs CS; Recine B; Moos RH
    Med Care; 1994 Jun; 32(6):535-50. PubMed ID: 8189773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of efforts to reduce inpatient costs on clinical effectiveness: treatment of posttraumatic stress disorder in the Department of Veterans Affairs.
    Rosenheck R; Fontana A
    Med Care; 2001 Feb; 39(2):168-80. PubMed ID: 11176554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders.
    Hoff RA; Rosenheck RA
    Med Care; 1998 Jun; 36(6):835-43. PubMed ID: 9630125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Average cost of VA rehabilitation, mental health, and long-term hospital stays.
    Yu W; Wagner TH; Chen S; Barnett PG
    Med Care Res Rev; 2003 Sep; 60(3 Suppl):40S-53S. PubMed ID: 15095545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative outcomes and costs of inpatient care and supportive housing for substance-dependent veterans.
    Schinka JA; Francis E; Hughes P; LaLone L; Flynn C
    Psychiatr Serv; 1998 Jul; 49(7):946-50. PubMed ID: 9661231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission.
    Swindle RW; Phibbs CS; Paradise MJ; Recine BP; Moos RH
    J Subst Abuse; 1995; 7(1):79-97. PubMed ID: 7655313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing readmission to substance abuse treatment as an indicator of outcome and program performance.
    Humphreys K; Weingardt KR
    Psychiatr Serv; 2000 Dec; 51(12):1568-9. PubMed ID: 11097655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of residential treatment of substance abuse in hospital- and community-based programs.
    Moos RH; King MJ; Patterson MA
    Psychiatr Serv; 1996 Jan; 47(1):68-74. PubMed ID: 8925349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stay in residential facilities and mental health care as predictors of readmission for patients with substance use disorders.
    Moos RH; Moos BS
    Psychiatr Serv; 1995 Jan; 46(1):66-72. PubMed ID: 7895125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic evaluation of inpatient residential treatment programs in the Department of Veterans Affairs.
    Wagner TH; Chen S
    Med Care Res Rev; 2005 Apr; 62(2):187-204. PubMed ID: 15750176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unit cost of counseling and patients length of stay in a residential drug treatment setting.
    Alemi F; Haack M; Holifield L; Claudio Y; Haqqi K
    J Ment Health Policy Econ; 2002 Sep; 5(3):103-7. PubMed ID: 12728196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program characteristics and readmission among older substance abuse patients: comparisons with middle-aged and younger patients.
    Moos RH; Mertens JR; Brennan PL
    J Ment Health Adm; 1995; 22(4):332-45. PubMed ID: 10172450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.